Table 4b.
Baseline | Follow-Up One | Follow-Up Two | ||||
---|---|---|---|---|---|---|
No TMQQ (n = 41) | Yes TMQQ (n = 39) | No TMQQ (n = 28) | Yes TMQQ (n = 32) | No TMQQ (n = 31) | Yes TMQQ (n = 27) | |
Motivation (0–100) | ||||||
Motivation for HIV Care | 89.1 (19.7) | 92.0 (12.1) | 96.0 (6.05) | 94.5 (8.35) | 95.6 (6.83) | 95.9 (9.06) |
Motivation for High HIV Medication Adherence | 82.0 (26.0) | 83.2 (19.3) | 93.9 (8.95) | 92.8 (9.35) | 96.0 (6.03) | 94.5 (11.2) |
Motivation for Undetectable Viral Load | 89.2 (19.8) | 88.7 (17.1) | 91.8 (17.0) | 91.4 (12.8) | 90.3 (15.4) | 95.2 (7.86) |
SF-12 health-related quality of life | ||||||
SF-6D health utility score | 0.671 (0.188) | 0.719 (0.184) | 0.682 (0.196) | 0.794 (0.172) | 0.729 (0.203) | 0.728 (0.182) |
SF-12 Physical health T-score | 42.2 (12.3) | 45.8 (10.4) | 42.8 (11.5) | 47.3 (10.2) | 45.8 (11.8) | 46.8 (10.5) |
SF-12 Mental health T-score | 44.4 (14.0) | 47.1 (10.6) | 45.7 (12.3) | 51.7 (7.77) | 46.1 (12.0) | 45.5 (10.1) |
HIV treatment engagement | ||||||
HIV Medication adherence (0–100) | 62.0 (40.8) | 54.6 (38.8) | 71.3 (25.7) | 66.8 (29.0) | 74.6 (23.4) | 73.4 (24.1) |
HIV Medication taken in Past 4 Weeks | 33 (80.5%) | 29 (74.4%) | 27 (96.4%) | 30 (93.8%) | 31 (100%) | 27 (100%) |
HIV viral load | ||||||
log10 HIV viral load† | 4.01 (0.87) | 3.83 (0.96) | 3.35 (1.45) | 3.30 (1.51) | 2.84 (1.45) | 3.45 (1.63) |
Suppressed (viral load < 200) | 0 (0%) | 0 (0%) | 8 (25.8%) | 8 (25.8%) | 11 (35.5%) | 9 (31.0%) |
†At Follow-Up One, viral load was available for 31 participants assigned to TMQQ and 31 participants not assigned to TMQQ. At Follow-Up Two, viral load was available for 29 participants assigned to TMQQ and 31 participants not assigned to TMQQ.
Assigned to TMQQ and 31 participants not assigned to TMQQ.